Background/Aims: We have demonstrated previously that bipolar electrocoagulation on functional cortex (BCFC) is a safe and effective approach for epilepsy involving eloquent areas. Here, we report the results of BCFC with lesionectomy for patients with epileptogenic foci partially overlapping eloquent areas. Methods: Forty patients who had been treated with lesionectomy with BCFC were retrospectively reviewed with regard to seizure outcome and neurological deficits. Ten similar patients who had received lesionectomy with multiple subpial transections (MST) were examined as a control group. Results: In the lesionectomy group with BCFC, Engel class I was achieved in 18 (45%) patients, class II in 8 (20%) patients, class III in 8 (20%) patients and class IV in 6 (15%) patients. Five (12.5%) patients developed mild hemiparesis and 1 (2.5%) patient mild sensory dysphasia. In the lesionectomy group with MST, Engel class I was achieved in 3 (30%) patients, class II in 2 (20%) patients, class III in 3 (30%) patients and class IV in 2 (20%) patients. Two (20%) patients developed mild hemiparesis and 1 (10%) patient moderate hemiparesis. All these complications recovered within 1-12 months. Conclusions: Compared with MST, the outcome of BCFC with lesionectomy is similar. But since MST leads to mechanical injury, while BCFC causes thermal injury, the complications of BCFC seem less severe. © 2014 S. Karger AG, Basel

Keywords:
Epilepsy, Bipolar electrocoagulation on functional cortex, Lesionectomy, Multiple subpial transections
1.
Cui ZQ, Luan GM, Zhou J: Pure bipolar electro-coagulation on functional cortex in the treatment of epilepsy involving eloquent areas. Epilepsy Res 2012;99:139-146.
2.
Luan GM, Sun ZR, Bai Q, Wang C: Surgical treatment of intractable epilepsy combined with bipolar electro-coagulation on functional cortex. Stereotact Funct Neurosurg 2001;77:233-238.
3.
Yang ZX, Luan GM: Treatment of symptomatic epilepsy with lesionectomies combined with bipolar coagulation of the surrounding cortex. Chin Med J 2003;116:1930-1932.
4.
Morrell F, Whisler WW, Bleck TP: Multiple subpial transection: a new approach to the surgical treatment of focal epilepsy. J Neurosurg 1989;70:231-239.
5.
Schramm J, Aliashkevich AF, Grunwald T: Multiple subpial transections: outcome and complications in 20 patients who did not undergo resection. J Neurosurg 2002;97:39-47.
6.
Engel J, Van Ness P, Rasmussen TB, Ojemann LM: Outcome with respect to epileptic seizures; in Engel J (ed): Surgical Treatment of the Epilepsies, ed 2. New York, Raven Press, 1993, pp 609-621.
7.
Hufnagel A, Zentner J, Fernandez G, Wolf HK, Schramm J, Elger CE: Multiple subpial transection for control of epileptic seizures: effectiveness and safety. Epilepsia 1997;38:678-688.
8.
Mulligan LP, Spencer DD, Spencer SS: Multiple subpial transection: the Yale experience. Epilepsia 2001;42:226-229.
9.
Orbach D, Romanelli P, Devinsky O, Doyle W: Late seizure recurrence after multiple subpial transection. Epilepsia 2001;42:1130-1133.
10.
Spencer SS, Schramm J, Wyler A, O'Connor M, Orbach D, Krauss G, Sperling M, Devinsky O, Elger C, Lesser R, Mulligan L, Westerveld M: Multiple subpial transection for intractable partial epilepsy: an international meta-analysis. Epilepsia 2002;43:141-145.
11.
Meng H, Luan GM: The experimental surgical technique research of cats' sensorimotor area cortex epileptogenic focus induced by penicillin. Part 2: histological observation. Chin J Stereotact Funct Neurosurg 1999;12:7-9.
12.
Devinsky O, Romanelli P, Orbach D, Pacia S, Doyle W: Surgical treatment of multifocal epilepsy involving eloquent cortex. Epilepsia 2003;44:718-723.
13.
Blount JP, Langburt W, Otsubo H, Chitoku S, Ochi A, Weiss S, Snead OC, Rutka JT: Multiple subpial transections in the treatment of pediatric epilepsy. J Neurosurg 2004;100:118-124.
14.
Chuang MF, Harnod T, Wang PJ, Chen YH, Hsin YL: Effect of multiple subpial transection on patients with uncontrolled atypical infantile spasms. Epilepsia 2006;47:659-660.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.